Pharmaceutical Filtration Market Size is projected to grow at a modest rate during 2022 to 2028 with increasing cases of airborne diseases and expansion of generics production. Investments in the research and development of biologics across advanced and emerging economies will boost industry growth.
Filtration has become a popular process in the pharmaceutical sector to help separate suspended particles. Pharmaceutical companies are investing in filtration technologies owing to rigorous cleanliness requirements and boosting the production of various large molecules. Moreover, an unprecedented rise in the manufacturing of vaccines has led to the use of filtration techniques. Soaring demand for advanced therapeutic drugs for the treatment of chronic diseases, including arthritis, cancer, and diabetes will drive the demand for filtration globally.
In terms of product, pharmaceutical membrane filters will expand at a robust growth rate during the forecast period 2022-2028. The equipment will gain prominence in a host of applications, including microfiltration, ultrafiltration, crossflow filtration, and nanofiltration. Robust development of drugs and the use of membrane filters in sterile filtration will augur well for the business outlook. Some of the factors, such as ease of installation and availability in a range of pore sizes and diameters will drive the demand for membrane filters.
Based on technique, microfiltration segment will grow with rising prominence across purification of cell broths and separation of macromolecules. The technology has gained prominence in the purification and recovery of biomass in the fermentation process and is used in harvesting cells in upstream bioprocessing. Developments in continuous processing and single-use disposable technologies could boost the use of microfiltration for deep filtration.
With respect to region, North America pharmaceutical filtration market forecast will be strong over 2022-2028 on account of the demand for biopharmaceuticals. Rising cases of airborne diseases and the infusion of funds into generics production have encouraged leading companies to invest in the region. Besides, growing awareness about nanofiber technologies, along with the usage of gene therapy, will augur well for regional growth.
The competitive profile of global pharmaceutical filtration market suggests leading companies could boost investments in research and development, mergers & acquisitions, innovations and technological advancements. Merck KGaA, Amazon Filters Ltd., GE Healthcare, 3M, Eaton Corporation Plc, Danaher Corporation, Meissner Filtration Products Inc., Sartorius Stedim Biotech S.A and Graver Technologies LLC, among others, are likely to boost the presence in the global pharmaceutical filtration market.
In May 2021, Meissner secured around USD 13.4 million contract from BARDA, the U.S. government agency, to bolster the production capability for components needed for vaccines and therapies. the company would be manufacturing single-use systems for filtration, filling assemblies, bottle assemblies and biocontainer assemblies, among others.
The COVID-19 pandemic played a pivotal role in expanding the penetration of filtration in the pharmaceutical industry. Filtration techniques will be sought-after in vaccine manufacturing across North America, Europe and the Asia Pacific. Considering the investments to overcome COVID-19 challenges, pharmaceutical filtration will continue to improve and evolve, becoming more advanced and agile. Emerging economies, such as China, India and Brazil have become a hub for pharmaceutical outsourcing and could provide lucrative opportunities over the next few years.
While high capital investments and challenges in obtaining FDA approvals are likely to hamper the industry outlook, widespread applications in vaccine processing will solidify the position of leading companies in the pharmaceutical filtration market.
Market, by Product
Market, by Technique
Market, by Application
Market, by Scale of Operation
The above information is provided for the following regions and countries: